[1] Panyutin IG,Neumann RD.Sequence-specific DNA double-strand breaks induced by tripex forming 125I labeled oligonucleotides[J].Nucleic Acid Res,1994,22:4979-4982.
[2] Larson SM,Tjuvajev J,Biasberg R.Triumph over mischance:a role for nuclear medicine in gene therapy[J].J Nucl Med,1997,38:1230-1233.
[3] Buchsbaum DJ,Raben D,Stackhouse M A,et al.Approaches to enhance cancer radiotherapy employing gene transfer methods[J].Gene Ther,1996,3(12):1042-1068.
[4] MairsRJ,Cunningham SH,Boyd M,et al.Applications of gene transfer to targeted radiotherapy[J].Curr Pharm Des,2000,6(14):1419-1432.
[5] Raben D,Buchsbaum DJ,Khazaeli MB,et al.Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinembryonic antigen gene[J].Gene Ther,1996,3(7):567-580.
[6] Szalai G,Williams LE,Primus FJ.Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model[J].Int J Cancer,2000,85(6):751-756.
[7] Buchsbaum DJ,Rogers BE,Khazaeli M B,et al.Targeting strategies for cancer radiotherapy[J].Clin Cancer Res,1999,5(10 Suppl):3048s-3055s.
[8] Shimura H,Haraguchi K,Miyazaki A,et al.Iodideuptake and experimental 131I therapy in transplanted undifferentiated thgroid cancer cells expressing the Na+/I- symporter gene[J].Endocrinology,1997,138(10):4493-4496.
[9] Mandell RB,Mandell LZ,Link CJ Jr.Radioisotope concentrator gen therapy using the sodium/iodide symporter gene[J].Cancer Res,1999,59(3):661-668.
[10] Cho JY,Xing S,Liu X,et al.Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery[J].Gene Ther,2000,7(9):740-749.
[11] Boyd M,Cunningham SH,Brown M M,et al.Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine[J].Gene Ther,1999,6(6):1147-1152.